Suchergebnisse - "EC 3.2.2.6"

PubPharm (3.283)

51

Efficacy of venetoclax plus anti-CD38 monoclonal antibody-containing therapies among t(11;14) positive multiple myeloma patients regardless of timing of prior treatment with this antibody

enthalten in: European journal of haematology | 2023

von Regidor, B. | Siddiqi, D. | Beatty, B. | +6

52

Evolving roles of CD38 metabolism in solid tumour microenvironment

enthalten in: British journal of cancer | 2023

von Gao, L. | Du, X. | Li, J. | +1

CommentIn: Br J Cancer. 2023 Feb;128(4):491. - PMID 36599916

53

The Role of CD38 in the Pathogenesis of Cardiorenal Metabolic Disease and Aging, an Approach from Basic Research

enthalten in: Cells | 2023

von Kitada, M. | Araki, S. | Koya, D.

54

Comment on : "Evolving roles of CD38 metabolism in solid tumour microenvironment"

enthalten in: British journal of cancer | 2023

von Nesmiyanov, P.

CommentOn: Br J Cancer. 2023 Feb;128(4):492-504. - PMID 36396822

55

Mechanism of CD38 via NAD+ in the Development of Non-alcoholic Fatty Liver Disease

enthalten in: International journal of medical sciences | 2023

von Dong, M. | Wang, S. | Pei, Z.

56

CD38 : an ecto-enzyme with functional diversity in T cells

enthalten in: Frontiers in immunology | 2023

von Ghosh, A. | Khanam, A. | Ray, K. | +4

57

Remission of social behavior impairment by oral administration of a precursor of NAD in CD157, but not in CD38, knockout mice

enthalten in: Frontiers in immunology | 2023

von Gerasimenko, M. | Higashida, H.

58

FTL004, an anti-CD38 mAb with negligible RBC binding and enhanced pro-apoptotic activity, is a novel candidate for treatments of multiple myeloma and non-Hodgkin lymphoma

enthalten in: Journal of hematology & oncology | 2022

von Zhang, G. | Guo, C. | Wang, Y. | +30

59

Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy

enthalten in: Blood cancer journal | 2022

von Mohyuddin, G. | Chakraborty, R. | Calip, G. | +10

60

The prognostic effect on childhood acute lymphoblastic leukemia of CD34+CD38- expressed in leukemia cells

enthalten in: Hematology (Amsterdam, Netherlands) | 2022

von Zhao, J. | Wang, Y. | Zhou, M. | +2